| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 26,060 | 42,418 | ||
| Short-term investments | 0 | 1,979 | ||
| Prepaid expenses and other current assets | 2,849 | 3,994 | ||
| Total current assets | 28,909 | 48,391 | ||
| Operating lease right-of-use assets | 29,031 | 33,529 | ||
| Property and equipment, net | 10,462 | 10,811 | ||
| Restricted cash | 1,976 | 1,976 | ||
| Deposit and other long-term assets | 2,023 | 1,472 | ||
| Total assets | 72,401 | 96,179 | ||
| Accounts payable | 12,459 | 4,748 | ||
| Accrued expenses and other current liabilities | 26,476 | 19,245 | ||
| Lease liability, current portion | 5,814 | 7,363 | ||
| Total current liabilities | 44,749 | 31,356 | ||
| Lease liability, net of current portion | 83,126 | 84,858 | ||
| Other non-current liabilities | 179 | 184 | ||
| Total liabilities | 128,054 | 116,398 | ||
| Preferred stock | 0 | 0 | ||
| Common stock | 2 | 2 | ||
| Additional paid-in capital | 1,155,598 | 1,143,391 | ||
| Accumulated other comprehensive loss | -440 | -451 | ||
| Accumulated deficit | -1,210,813 | -1,163,161 | ||
| Total stockholders (deficit) equity | -55,653 | -20,219 | ||
| Total liabilities and stockholders (deficit) equity | 72,401 | 96,179 | ||
Adverum Biotechnologies, Inc. (ADVM)
Adverum Biotechnologies, Inc. (ADVM)